Year: 2021

AXIM® Biotechnologies Releases Preprint Manuscript Describing the Development of Company’s Rapid Point-of-Care Test That Measures COVID-19 Neutralizing Antibodies

SAN DIEGO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare...

EnWave Signs Technology Evaluation and License Option Agreement with SunRhize Foods to Develop Plant-Based Tempeh Snacks and Reserves REVworx™ Toll Manufacturing Capacity

SunRhize Foods SunRhize Foods, Inc. aims to advance the alternative protein movement and transform the tempeh category by offering satisfying,...

error: Content is protected !!